The possible role of the Akt signaling pathway in schizophrenia

Wenhua Zheng1, Haitao Wang, Zhiwen Zeng

  • 1Neuropharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. whzheng123@gmail.com

Brain Research
|July 10, 2012
PubMed

Insights

Reduced activity of the Akt signaling pathway is implicated in schizophrenia, affecting cognitive function and neuronal health. Targeting Akt may offer a novel therapeutic strategy for this devastating psychiatric disorder.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • Schizophrenia is a severe psychiatric disorder with complex pathophysiology.
  • The Akt signaling pathway, a key regulator of cell survival and function, is increasingly implicated in brain disorders.
  • Evidence suggests Akt pathway dysregulation contributes to schizophrenia's development and progression.

Purpose of the Study:

  • To review the role of the Akt signaling pathway in the pathophysiology of schizophrenia.
  • To explore Akt as a potential therapeutic target for schizophrenia treatment.

Main Methods:

  • Review of genetic linkage and association studies identifying Akt-1 as a schizophrenia susceptibility gene.
  • Analysis of studies examining Akt-1 protein levels and kinase activity in patients.
  • Examination of research on upstream and downstream Akt pathway alterations in psychiatric disorders.
  • Investigation of antipsychotic drug effects on the Akt pathway.
  • Review of Akt's role in neurodevelopment, synaptic plasticity, and neurotransmission.

Main Results:

  • Akt-1 is a candidate gene for schizophrenia.
  • Significantly decreased Akt-1 protein levels and kinase activity observed in schizophrenic patients.
  • Alterations in Akt signaling pathways are found in various psychiatric disorders.
  • Antipsychotic drugs modulate the Akt signaling pathway.
  • Reduced PI3K/Akt signaling may underlie cognitive impairment and neuronal abnormalities in schizophrenia.

Conclusions:

  • Akt signaling pathway plays a crucial role in schizophrenia pathophysiology.
  • Akt deficiency may exacerbate the effects of genetic risk factors and reduce treatment response.
  • Targeting the Akt pathway presents a promising therapeutic strategy for schizophrenia.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...